Nearly one in five counties across the United States lack psychiatrists or internet service, making it difficult for around 10.5 million Americans to find mental health care, a new study shows.
Young people’s mental health deteriorated at greater rate during the pandemic, finds study
Researchers led by Professor Willem Kuyken at Oxford University’s Department of Psychiatry compared the mental health difficulties and well-being of thousands of UK secondary school pupils who experienced three lockdowns, with a group of students who participated in the same study before the coronavirus pandemic emerged in 2020.
Study suggests link between tear gas exposures and adverse reproductive health outcomes
In the wake of nationwide protests following the murder of George Floyd in May 2020, anecdotal reports of irregular menstrual cycles emerged among protestors who were exposed to tear gas used by law enforcement. Those reports—and the fact that the reproductive health effects of exposure to tear gas and other chemical agents is largely unknown—were the impetus for a new study from the University of Minnesota School of Public Health (SPH).
Diabetes drug maker sues over compounded versions of Mounjaro
Another diabetes drug maker is taking legal action against businesses in several states, alleging that they’re “fraudulently claiming” that their compounded products are the same as its medication.
Acrimonious Miles to return to PF secretariat tomorrow
…but Emmanuel Mwamba warns Mr Sampa will be trespassing and therefore shall not be allowed
By NATION REPORTER
ACRIMONIOUS and disgruntled Patriotic Front (PF) Matero Member of Parliament Miles Sampa is still in a provocative spirit and has dared that he will tomorrow hold press conference at the PF Secretariat, which he allegedly vandalized a few days ago using suspected hired UPND cadres.
This content is locked
This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.
Moms’ ability to ‘remember’ prior pregnancies suggests new strategies for preventing complications
Scientists have known for decades that pregnancy requires a mother’s body to adjust so that her immune system does not attack the growing fetus as if it were a hostile foreign invader. Yet despite learning a great deal more about the immunology of pregnancy in recent years, a new study shows that the cellular cross-talk between a mother and her offspring is even more complex and long-lasting than expected.
Rewiring tumor mitochondria enhances the immune system’s ability to recognize and fight cancer
Immunotherapy, which uses the body’s own immune system to fight cancer, is an effective treatment option, yet many patients do not respond to it. Thus, cancer researchers are seeking new ways to optimize immunotherapy so that it is more effective for more people.
Regeneration across complete spinal cord injuries reverses paralysis
When the spinal cords of mice and humans are partially damaged, the initial paralysis is followed by the extensive, spontaneous recovery of motor function. However, after a complete spinal cord injury, this natural repair of the spinal cord doesn’t occur and there is no recovery. Meaningful recovery after severe injuries requires strategies that promote the regeneration of nerve fibers, but the requisite conditions for these strategies to successfully restore motor function have remained elusive.
Personalized cancer vaccine and adoptive T cell therapy benefits patients with advanced ovarian cancer: Study
A Ludwig Cancer Research study has shown that combining adoptive T cell therapy (ACT) with an innovative, personalized cancer vaccine under development at the Lausanne Branch of the Ludwig Institute for Cancer Research can benefit patients with late-stage, drug-resistant ovarian cancer.
New treatment approach selectively targets cancer cell lysosomes and overcomes drug resistance
An anticancer treatment technology that selectively targets cancer cell lysosomes and overcomes drug resistance has been developed by Professor Ja-Hyoung Ryu and his research team in the Department of Chemistry at UNIST. This pioneering research promises a new paradigm for chemical anticancer drugs in the future.